Skip to main content

Table 2 Survival analysis results derived using the Kaplan–Meier method. The number of viral survival days for each group is shown

From: Efficacy of povidone-iodine nasal rinse and mouth wash in COVID-19 management: a prospective, randomized pilot clinical trial (povidone-iodine in COVID-19 management)

 

Days

p*

Mean (SE) [CI]

Median (SE) [CI]

PVP-I group (n = 5)

9.8 (0.8) [8.3–11.2]

9 (1) [7–11]

 

NS group (n = 6)

12 (2.1) [7.9–16.1]

12 (4.4) [3.4–20.6]

0.046

Control group (n = 8)

12.6 (0.6) [11.5–13.7]

12 (0.7) [10.7–13.3]

 
  1. SE: Standard error; CI: Confidence interval; PVP-I: Povidone-Iodine; NS: Normal Saline
  2. * Using log-rank (Mantel–Cox) test
  3. * p < 0.05 considered statistically significant
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us